FDAnews Drug Daily Bulletin

Celladon Mydicar Drug Receives FDA Fast Track Status

Dec. 14, 2011
A A
Celladon’s investigational product candidate, Mydicar, has been granted fast track designation by the FDA, used to treat patients with advanced heart failure.
Pharmaceutical Business Review